发明名称 |
Use of pidotimod to treat irritable bowel syndrome |
摘要 |
The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat irritable bowel syndrome. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally. |
申请公布号 |
US9408833(B2) |
申请公布日期 |
2016.08.09 |
申请号 |
US201314781755 |
申请日期 |
2013.04.05 |
申请人 |
POLICHEM SA |
发明人 |
Mailland Federico;Scarci Francesco;Caserini Maurizio |
分类号 |
A61K31/427;A61K45/06;A61K9/00;A61K47/10;A61K47/12;A61K47/18;A61K9/06;A61K9/08;A61K47/36;A61K9/16;A61K9/20 |
主分类号 |
A61K31/427 |
代理机构 |
Fredrikson & Byron, P.A. |
代理人 |
Fredrikson & Byron, P.A. |
主权项 |
1. A method of treating irritable bowel syndrome in a patient, comprising administering to the patient pidotimod or a physiologically acceptable salt thereof. |
地址 |
Luxembourg LU |